Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 459

1.

Effect of letermovir on levonorgestrel and ethinyl estradiol pharmacokinetics
.

Adedoyin A, Cho CR, Fox-Bosetti S, Macha S, Zhao T, Liu F, Panebianco D, O'Reilly TE, McCrea J, Stoch SA, Iwamoto M.

Int J Clin Pharmacol Ther. 2019 Sep;57(9):450-457. doi: 10.5414/CP203483.

PMID:
31232280
2.

Evaluation of folic acid supplementation by concomitant administration of ethinyl estradiol + levonorgestrel in healthy female subjects
.

de Moraes Jacob J, de Jesus Antunes N, Moreno R, De Nucci G.

Int J Clin Pharmacol Ther. 2019 Jun;57(6):290-297. doi: 10.5414/CP203293.

PMID:
30900980
3.

Short article: Hormone therapy for severe gastrointestinal bleeding due to multiple angiodysplastic lesions.

Torrente Iranzo S, Sarasqueta Eizaguirre C, Gonzalez Canalizo V, Segues Merino NM, Ortega Rezola P, Wong Arteta J, Medina Del Valle A, Cosme Jimenez Á, Bujanda L.

Eur J Gastroenterol Hepatol. 2019 Mar;31(3):312-315. doi: 10.1097/MEG.0000000000001139.

PMID:
30676471
4.

Ethinylestradiol and Levonorgestrel as Active Agents in Normal Skin, and Pathological Conditions Induced by UVB Exposure: In Vitro and In Ovo Assessments.

Coricovac D, Farcas C, Nica C, Pinzaru I, Simu S, Stoian D, Soica C, Proks M, Avram S, Navolan D, Dumitru C, Popovici RA, Dehelean CA.

Int J Mol Sci. 2018 Nov 14;19(11). pii: E3600. doi: 10.3390/ijms19113600.

5.

The effect of laquinimod, a novel immuno-modulator in development to treat Huntington disease, on the pharmacokinetics of ethinylestradiol and levonorgestrel in healthy young women.

Elgart A, Zur AA, Mimrod D, Dror V, Bar-Ilan O, Korver T, Spiegelstein O.

Eur J Clin Pharmacol. 2019 Jan;75(1):41-49. doi: 10.1007/s00228-018-2549-7. Epub 2018 Sep 6.

PMID:
30191262
6.

Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique®) in the treatment of endometriosis symptoms: A prospective open-label comparative study.

Scala C, Leone Roberti Maggiore U, Barra F, Venturini PL, Ferrero S.

Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:89-94. doi: 10.1016/j.ejogrb.2018.01.022. Epub 2018 Feb 3.

PMID:
29408753
7.

Oral hormonal therapy with ethinylestradiol-levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating mineralocorticoid in estrogen-deficient rats.

Adeyanju OA, Soetan OA, Soladoye AO, Olatunji LA.

Can J Physiol Pharmacol. 2018 Jun;96(6):577-586. doi: 10.1139/cjpp-2017-0630. Epub 2018 Feb 3.

PMID:
29400073
8.

Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study.

Johnson-Agbakwu C, Brown L, Yuan J, Kissling R, Greenblatt DJ.

Clin Ther. 2018 Jan;40(1):64-73. doi: 10.1016/j.clinthera.2017.08.021. Epub 2017 Dec 2.

9.

Hypercupremia secondary to oral contraceptives: report of 2 cases.

Araujo Castro M, Prieto Coca L, Izquierdo Álvarez C, Oliván Palacios B, Campos Del Portillo R.

Endocrinol Diabetes Nutr. 2017 Nov;64(9):509-511. doi: 10.1016/j.endinu.2017.08.002. Epub 2017 Sep 18. English, Spanish. No abstract available.

PMID:
29050708
10.
11.

Phototoxic reaction to a combined oral contraceptive (levonorgestrel/ethinylestradiol).

Richarz NA, Aguilera J, Castillo G, Fuente MJ, Ferrándiz C, Carrascosa JM.

Photochem Photobiol Sci. 2017 Sep 13;16(9):1381-1383. doi: 10.1039/c7pp00160f.

PMID:
28825075
12.

Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.

Hasegawa S, Matsui T, Hane Y, Abe J, Hatahira H, Motooka Y, Sasaoka S, Fukuda A, Naganuma M, Hirade K, Takahashi Y, Kinosada Y, Nakamura M.

PLoS One. 2017 Jul 21;12(7):e0182045. doi: 10.1371/journal.pone.0182045. eCollection 2017.

13.

[Efficacy and impact on quality of life of different drug treatments after partial resection of rectovaginal endometriosis].

Li T, Xu XX, Dai Y, Zhang JJ, Lang JH, Leng JH.

Zhonghua Fu Chan Ke Za Zhi. 2017 May 25;52(5):307-313. doi: 10.3760/cma.j.issn.0529-567X.2017.05.004. Chinese.

PMID:
28545268
14.

Combined oral contraceptive and nitric oxide synthesis inhibition synergistically causes cardiac hypertrophy and exacerbates insulin resistance in female rats.

Olatunji LA, Olaniyi KS, Usman TO, Abolarinwa BA, Achile CJ, Kim IK.

Environ Toxicol Pharmacol. 2017 Jun;52:54-61. doi: 10.1016/j.etap.2017.03.012. Epub 2017 Mar 20.

PMID:
28376377
15.

Anti-inflammatory and antithrombotic effects of nicotine exposure in oral contraceptive-induced insulin resistance are glucocorticoid-independent.

Olatunji LA, Michael OS, Adeyanju OA, Areola ED, Soladoye AO.

Pharmacol Rep. 2017 Jun;69(3):512-519. doi: 10.1016/j.pharep.2016.12.010. Epub 2016 Dec 19.

PMID:
28349880
16.

No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrel.

Marshall WL, Feng HP, Caro L, Talaty J, Guo Z, Huang X, Panebianco D, Ma J, Mangin E, O'Reilly TE, Butterton JR, Yeh WW.

Eur J Clin Pharmacol. 2017 May;73(5):593-600. doi: 10.1007/s00228-017-2216-4. Epub 2017 Feb 24.

PMID:
28233047
17.

Endogenous thrombin potential changes during the first cycle of oral contraceptive use.

Westhoff CL, Pike MC, Cremers S, Eisenberger A, Thomassen S, Rosing J.

Contraception. 2017 May;95(5):456-463. doi: 10.1016/j.contraception.2017.01.001. Epub 2017 Jan 11.

18.

Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult women.

Trezza C, Ford SL, Gould E, Lou Y, Huang C, Ritter JM, Buchanan AM, Spreen W, Patel P.

Br J Clin Pharmacol. 2017 Jul;83(7):1499-1505. doi: 10.1111/bcp.13236. Epub 2017 Feb 14.

19.

Estimating systemic exposure to levonorgestrel from an oral contraceptive.

Basaraba CN, Westhoff CL, Pike MC, Nandakumar R, Cremers S.

Contraception. 2017 Apr;95(4):398-404. doi: 10.1016/j.contraception.2016.12.007. Epub 2016 Dec 30.

20.

Comparison of combined hormonal vaginal ring and low dose combined oral hormonal pill for the treatment of idiopathic chronic pelvic pain: a randomised trial.

Priya K, Rajaram S, Goel N.

Eur J Obstet Gynecol Reprod Biol. 2016 Dec;207:141-146. doi: 10.1016/j.ejogrb.2016.10.026. Epub 2016 Nov 8.

PMID:
27863271

Supplemental Content

Loading ...
Support Center